1
|
Allera H, Cohu M, Maley K, Crabot D, Karila-Cohen P, Strauss C, Lidove O, Cotto E. [Thoracic calcifications]. Rev Med Interne 2024; 45:176-177. [PMID: 37833151 DOI: 10.1016/j.revmed.2023.08.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2023] [Accepted: 08/13/2023] [Indexed: 10/15/2023]
Affiliation(s)
- H Allera
- Service de gériatrie aiguë, groupe hospitalier Diaconesses Croix Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| | - M Cohu
- Service de gériatrie aiguë, groupe hospitalier Diaconesses Croix Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| | - K Maley
- Service de gériatrie aiguë, groupe hospitalier Diaconesses Croix Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| | - D Crabot
- Service de gériatrie aiguë, groupe hospitalier Diaconesses Croix Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| | - P Karila-Cohen
- Service de radiologie, groupe hospitalier Diaconesses Croix Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| | - C Strauss
- Service de radiologie, groupe hospitalier Diaconesses Croix Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| | - O Lidove
- Service de médecine interne, groupe hospitalier Diaconesses Croix Saint-Simon, 125, rue d'Avron, 75020 Paris, France.
| | - E Cotto
- Service de gériatrie aiguë, groupe hospitalier Diaconesses Croix Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| |
Collapse
|
2
|
Mauhin W, Brassier A, London J, Subran B, Zeggane A, Besset Q, Jammal C, Montardi C, Mellot C, Strauss C, Borie R, Lidove O. Manifestations pulmonaires des maladies héréditaires du métabolisme. Rev Mal Respir 2022; 39:758-777. [DOI: 10.1016/j.rmr.2022.09.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2022] [Accepted: 09/11/2022] [Indexed: 11/05/2022]
|
3
|
Mauhin W, Tebani A, Amelin D, Abily-Donval L, Lamari F, London J, Douillard C, Dussol B, Leguy-Seguin V, Noel E, Masseau A, Lacombe D, Maillard H, Bekri S, Lidove O, Benveniste O. Augmentation de la sphingosine-1-phosphate chez les patients atteints de maladie de Fabry avec phénotype non classique. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.03.296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
4
|
Mauhin W, Belmatoug N, Berger M, Besset Q, Boitiaux J, Brassier A, Douillard C, Gousseff M, Lavigne C, Martis N, Mellot C, Nguyen A, Subran B, Klein E, Strauss C, Guillot E, Lidove O. Accès compassionnel à l’enzymothérapie chez les patients adultes avec déficit en sphingomyélinase acide (Niemann-Pick B) en France : expérience multicentrique. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.03.253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
5
|
Mauhin W, Levade T, Vanier M, Froissart R, Lidove O. Surrisque de cancer au cours du déficit en sphingomyélinase acide (maladie de Niemann-Pick B). Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.03.251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
6
|
Subran B, Mauhin W, London J, Montagner C, Mellot C, Lidove O. Responsabilisation des externes quand à l’apprentissage de la sémiologie en stage hospitalier. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.10.228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Mauhin W, Bouzidi H, Colson A, Lejour G, Miao Y, Montagner C, London J, Subran B, Amathieu R, Lazard T, Lidove O. [Fatal nutrient deficiencies after gastric bypass]. Rev Med Interne 2021; 42:729-733. [PMID: 34144843 DOI: 10.1016/j.revmed.2021.05.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Revised: 04/01/2021] [Accepted: 05/09/2021] [Indexed: 11/16/2022]
Abstract
INTRODUCTION Bariatric surgery is a very effective treatment for obesity. After gastric bypass, micronutrient deficiencies frequently occur which can have dramatic consequences. CASE REPORT We report the case of a 55-year-old woman who was admitted for psychomotor retardation, bilateral leg pitting edema and psoriasis-like rash that had been ongoing for 3 months. Pancytopenia, encephalopathy and heart failure rapidly occurred leading to multiorgan dysfunction syndrome and death. We retrospectively identified severe selenium deficiency with possible secondary cardiomyopathy, niacin deficiency resulting in pellagrous encephalopathy with skin lesions and gelatinous transformation of bone marrow. CONCLUSION Micronutrient deficiency should systematically be assessed when new symptoms occur in a patient with a history of bariatric surgery. Selenium deficiency should be considered in the presence of any heart failure in this context.
Collapse
Affiliation(s)
- W Mauhin
- Service de médecine interne, groupe hospitalier Diaconesses Croix-Saint-Simon, site Avron, 75020 Paris, France.
| | - H Bouzidi
- Service de réanimation, groupe hospitalier Diaconesses Croix-Saint-Simon, site Avron, 75020 Paris, France
| | - A Colson
- Service transversal de nutrition et diététique, Paris, France
| | - G Lejour
- Service de réanimation, groupe hospitalier Diaconesses Croix-Saint-Simon, site Avron, 75020 Paris, France
| | - Y Miao
- Service de médecine interne, groupe hospitalier Diaconesses Croix-Saint-Simon, site Avron, 75020 Paris, France
| | - C Montagner
- Service de médecine interne, groupe hospitalier Diaconesses Croix-Saint-Simon, site Avron, 75020 Paris, France
| | - J London
- Service de médecine interne, groupe hospitalier Diaconesses Croix-Saint-Simon, site Avron, 75020 Paris, France
| | - B Subran
- Service de médecine interne, groupe hospitalier Diaconesses Croix-Saint-Simon, site Avron, 75020 Paris, France
| | - R Amathieu
- Service de réanimation, groupe hospitalier Diaconesses Croix-Saint-Simon, site Avron, 75020 Paris, France
| | - T Lazard
- Service de réanimation, groupe hospitalier Diaconesses Croix-Saint-Simon, site Avron, 75020 Paris, France
| | - O Lidove
- Service de médecine interne, groupe hospitalier Diaconesses Croix-Saint-Simon, site Avron, 75020 Paris, France
| |
Collapse
|
8
|
Moreno-Martinez D, Aguiar P, Auray-Blais C, Beck M, Bichet DG, Burlina A, Cole D, Elliott P, Feldt-Rasmussen U, Feriozzi S, Fletcher J, Giugliani R, Jovanovic A, Kampmann C, Langeveld M, Lidove O, Linhart A, Mauer M, Moon JC, Muir A, Nowak A, Oliveira JP, Ortiz A, Pintos-Morell G, Politei J, Rozenfeld P, Schiffmann R, Svarstad E, Talbot AS, Thomas M, Tøndel C, Warnock D, West ML, Hughes DA. Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus. Mol Genet Metab 2021; 132:234-243. [PMID: 33642210 DOI: 10.1016/j.ymgme.2021.02.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2020] [Revised: 02/01/2021] [Accepted: 02/01/2021] [Indexed: 12/21/2022]
Abstract
BACKGROUND Recent years have witnessed a considerable increase in clinical trials of new investigational agents for Fabry disease (FD). Several trials investigating different agents are currently in progress; however, lack of standardisation results in challenges to interpretation and comparison. To facilitate the standardisation of investigational programs, we have developed a common framework for future clinical trials in FD. METHODS AND FINDINGS A broad consensus regarding clinical outcomes and ways to measure them was obtained via the Delphi methodology. 35 FD clinical experts from 4 continents, representing 3389 FD patients, participated in 3 rounds of Delphi procedure. The aim was to reach a consensus regarding clinical trial design, best treatment comparator, clinical outcomes, measurement of those clinical outcomes and inclusion and exclusion criteria. Consensus results of this initiative included: the selection of the adaptative clinical trial as the ideal study design and agalsidase beta as ideal comparator treatment due to its longstanding use in FD. Renal and cardiac outcomes, such as glomerular filtration rate, proteinuria and left ventricular mass index, were prioritised, whereas neurological outcomes including cerebrovascular and white matter lesions were dismissed as a primary or secondary outcome measure. Besides, there was a consensus regarding the importance of patient-related outcomes such as general quality of life, pain, and gastrointestinal symptoms. Also, unity about lysoGb3 and Gb3 tissue deposits as useful surrogate markers of the disease was obtained. The group recognised that cardiac T1 mapping still has potential but requires further development before its widespread introduction in clinical trials. Finally, patients with end-stage renal disease or renal transplant should be excluded unless a particular group for them is created inside the clinical trial. CONCLUSION This consensus will help to shape the future of clinical trials in FD. We note that the FDA has, coincidentally, recently published draft guidelines on clinical trials in FD and welcome this contribution.
Collapse
Affiliation(s)
- D Moreno-Martinez
- Lysosomal Storage Disorders Unit, Royal Free Hospital NHS Foundation Trust and University College London, London, UK
| | - P Aguiar
- Inborn Errors of Metabolism Reference Centre, North Lisbon Hospital Centre, Lisbon, Portugal
| | - C Auray-Blais
- Division of Medical Genetics, Department of Pediatrics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Canada
| | - M Beck
- Institute of Human Genetics, University Medical Centre, University of Mainz, Mainz, Germany
| | - D G Bichet
- Unité de Recherche Clinique, Centre de Recherche et Service de Néphrologie, Hôpital du Sacré-Coeur de Montreal, Montreal, Quebec, Canada
| | - A Burlina
- Neurological Unit, St. Bassiano Hospital, Bassano del Grappa, Italy
| | - D Cole
- Department of Medical Biochemistry and Immunology, University Hospital of Wales, Cardiff, Wales, UK
| | - P Elliott
- Barts Cardiac Centre, University College London, London, UK
| | - U Feldt-Rasmussen
- Medical Endocrinology and Metabolism, Rigshospitalet, Copenhagen, Denmark
| | - S Feriozzi
- Division of Nephrology, Belcolle Hospital, Viterbo, Italy
| | - J Fletcher
- Genetics and Molecular Pathology, SA Pathology Women's and Children's Hospital, North Adelaide, Australia
| | - R Giugliani
- Medical Genetics Service, HCPA, Department of Genetics, UFRGS, Porto Alegre, Rio Grande do Sul, Brazil
| | - A Jovanovic
- Department of Endocrinology and Metabolic Medicine, Salford Royal NHS Foundation Trust, Salford, UK
| | - C Kampmann
- Centre for Paediatric and Adolescent Medicine, University Medical Centre, University of Mainz, Mainz, Germany
| | - M Langeveld
- Department of Endocrinology and Metabolism, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
| | - O Lidove
- Department of Internal Medicine, Université Paris 7, Hôpital Bichat Claude-Bernard, Paris, France
| | - A Linhart
- Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
| | - M Mauer
- Department of Paediatrics, University of Minnesota, Minneapolis, MN, United States
| | - J C Moon
- Cardiac Imaging Department, Barts Heart Centre, London, UK
| | - A Muir
- Belfast Heart Centre, Royal Victoria Hospital, Belfast, UK
| | - A Nowak
- Department of Endocrinology and Clinical Nutrition, University Hospital Zurich and University of Zurich, Zurich, Switzerland
| | - J P Oliveira
- Service of Medical Genetics, São João University Hospital Centre, Alameda Hernãni Monteiro, Porto, Portugal
| | - A Ortiz
- Fundación Jiménez Díaz (IIS-FJD) Área de Patología Cardiovascular, Renal e Hipertensión, Madrid, Spain
| | - G Pintos-Morell
- Rare and Metabolic Diseases Unit, Vall Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - J Politei
- Fundation for the Study of Neurometabolic Diseases, FESEN, Argentina
| | - P Rozenfeld
- Departamento de Ciencias Biológicas, CONICET, Facultad de Ciencias Exactas, IIFP, Universidad Nacional de La Plata, La Plata, Argentina
| | - R Schiffmann
- Institute of Metabolic Disease, Baylor Research Institute, Dallas, TX, USA
| | - E Svarstad
- Department of Clinical Medicine, University of Bergen and Haukeland University Hospital, Bergen, Norway
| | - A S Talbot
- Department of Nephrology, Royal Melbourne Hospital, Melbourne, Victoria, Australia
| | - M Thomas
- Department of Nephrology, Royal Perth Hospital, Perth, Western Australia, Australia
| | - C Tøndel
- Clinical Trials Unit, Haukeland University Hospital, Bergen, Norway
| | - D Warnock
- Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA
| | - M L West
- Medicine, Dalhousie University, Halifax, Nova Scotia, Canada
| | - D A Hughes
- Lysosomal Storage Disorders Unit, Royal Free Hospital NHS Foundation Trust and University College London, London, UK.
| |
Collapse
|
9
|
Prié H, Meyssonnier V, Kerroumi Y, Heym B, Lidove O, Marmor S, Zeller V. Infection de prothèse articulaire à Pseudomonas aeruginosa : évolution à 2 ans de 44 patients. Med Mal Infect 2020. [DOI: 10.1016/j.medmal.2020.06.272] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
10
|
Sené T, Clavel G, Villeneuve D, Philibert M, Mauget-Faÿsse M, Lamirel C, Lecler A, Gout O, Hage R, Lidove O, Vignal-Clermont C. [Delays in the management of ocular complications of giant cell arteritis: A retrospective monocentric study of 33 patients]. Rev Med Interne 2020; 41:661-666. [PMID: 32682624 DOI: 10.1016/j.revmed.2020.06.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Revised: 06/05/2020] [Accepted: 06/22/2020] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Ocular complications of giant cell arteritis (GCA) can lead to irreversible bilateral blindness and represent a therapeutic emergency. Recommendations for the management of GCA have recently been updated. The objective of the study was to evaluate delays in appropriate management of the ocular complications of GCA and its determinants. METHOD Retrospective, monocentric study, conducted over the period January 2013-November 2018. All consecutive patients with a final diagnosis of GCA and related visual impairment (permanent visual loss and/or alteration of visual field) were included. RESULTS Thirty-three patients were included (women: 21, men: 12; mean age at diagnosis: 79). Twenty-seven patients (82%) presented with symptoms suggestive of ACG prior to the visual complication, ranging from a few weeks to several months. Seventeen patients (52%) had a known biological inflammatory syndrome (median CRP at 64 mg/L) prior to hospital consultation. The median time from the onset of permanent ophthalmologic manifestations to appropriate corticosteroid management was 3 days (range: 0-134). Two of the 21 patients who consulted an out-of-hospital ophthalmologist received corticosteroid therapy before referral to hospital. Three patients (9%) were treated within 24 h of the onset of the disorders. CONCLUSION There is a significant delay in the appropriate management of ophthalmological complications of ACG and deviations from current recommendations. Numerous actions must therefore be taken to improve the visual prognosis of patients with ACG, both preventively (i.e. early diagnosis and treatment of ACG before the possible occurrence of visual complications), and curatively (rapid recognition and immediate treatment of ocular complications). These elements support the relevance of specific fast-track pathways for GCA.
Collapse
Affiliation(s)
- T Sené
- Service de Médecine Interne, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France; Service de Médecine Interne, Hôpital de la Croix Saint-Simon - Groupe Hospitalier Diaconesses-Croix Saint-Simon, 75020 Paris, France.
| | - G Clavel
- Service de Médecine Interne, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France
| | - D Villeneuve
- Service de Médecine Interne, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France
| | - M Philibert
- Service de Neuro-Ophtalmologie, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France
| | - M Mauget-Faÿsse
- Centre d'Investigations Cliniques, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France
| | - C Lamirel
- Service d'Ophtalmologie, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France
| | - A Lecler
- Service d'Imagerie, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France
| | - O Gout
- Service de Neurologie, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France
| | - R Hage
- Service de Neuro-Ophtalmologie, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France
| | - O Lidove
- Service de Médecine Interne, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France; Service de Médecine Interne, Hôpital de la Croix Saint-Simon - Groupe Hospitalier Diaconesses-Croix Saint-Simon, 75020 Paris, France
| | - C Vignal-Clermont
- Service de Neuro-Ophtalmologie, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France; Service des Urgences Ophtalmologiques, Hôpital Fondation Adolphe de Rothschild, 75019 Paris, France
| |
Collapse
|
11
|
Affiliation(s)
- Y Miao
- Internal Medicine Department, Diaconesses Croix Saint Simon Hospital, Paris, France
| | - O Lidove
- Internal Medicine Department, Diaconesses Croix Saint Simon Hospital, Paris, France
| | - W Mauhin
- Internal Medicine Department, Diaconesses Croix Saint Simon Hospital, Paris, France
| |
Collapse
|
12
|
Fredeau L, Karaa S, London J, Matignon MB, Blah N, Montagner C, Lidove O, Mauhin W. Image Gallery: Palmar vascular lesions, a tool for diagnosis and prognosis in Fabry disease. Br J Dermatol 2019; 182:e183. [PMID: 31875942 DOI: 10.1111/bjd.18786] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- L Fredeau
- Internal Medicine, Groupe Hospitalier Diaconesses Croix Saint-Simon Site Avron, Paris, France
| | - S Karaa
- Internal Medicine, Groupe Hospitalier Diaconesses Croix Saint-Simon Site Avron, Paris, France
| | - J London
- Internal Medicine, Groupe Hospitalier Diaconesses Croix Saint-Simon Site Avron, Paris, France.,Centre de Référence Maladies Lysosomales, Hôpital de la Croix Saint-Simon, Paris, France
| | - M B Matignon
- Nephrology and Renal Transplantation Department, Institut Francilien de Recherche en Néphrologie et Transplantation, Henri-Mondor/Albert-Chenevier University Hospital, APHP, Créteil, France.,University of Paris-Est-Créteil, Département Hospitalo-Universitaire Virus-Immunité-Cancer, Institut Mondor de Recherche Biomédicale, Team 21, INSERM U955, Créteil, France
| | - N Blah
- Internal Medicine, Groupe Hospitalier Diaconesses Croix Saint-Simon Site Avron, Paris, France
| | - C Montagner
- Internal Medicine, Groupe Hospitalier Diaconesses Croix Saint-Simon Site Avron, Paris, France.,Centre de Référence Maladies Lysosomales, Hôpital de la Croix Saint-Simon, Paris, France
| | - O Lidove
- Internal Medicine, Groupe Hospitalier Diaconesses Croix Saint-Simon Site Avron, Paris, France.,Centre de Référence Maladies Lysosomales, Hôpital de la Croix Saint-Simon, Paris, France
| | - W Mauhin
- Internal Medicine, Groupe Hospitalier Diaconesses Croix Saint-Simon Site Avron, Paris, France.,Centre de Référence Maladies Lysosomales, Hôpital de la Croix Saint-Simon, Paris, France
| |
Collapse
|
13
|
Deriaz S, Serratrice C, Lidove O, Noël E, Masseau A, Lorcerie B, Jaussaud R, Marie I, Lavigne C, Cabane J, Kaminsky P, Chérin P, Maillot F. [Diagnostic journey of type 1 Gaucher Disease patients: A survey including internists and hematologists]. Rev Med Interne 2019; 40:778-784. [PMID: 31500934 DOI: 10.1016/j.revmed.2019.07.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2018] [Revised: 06/22/2019] [Accepted: 07/15/2019] [Indexed: 10/26/2022]
Abstract
INTRODUCTION Gaucher disease (GD) is a rare genetic lysosomal storage disorder caused by a beta-glucocerebrosidase deficiency and responsible for a lysosomal storage disorder. GD is characterized by haematological, visceral and bone involvements. The aim of this study was to describe the diagnostic journey of type 1 GD patients as well as the role of the internist. METHODS A retrospective multicentric study involving type 1 GD patients has been conducted in 16 centers, between 2009 and 2011. RESULTS Fifty-five type 1 GD patients were included, under the care of an internist or an haematologist. They were originally hospitalized in 8 different specialized units. Diagnosis was established by bone-marrow aspiration in 22 patients (40%), by enzymatic assay of glucocerebrosidase activity in 15 patients (27%), and by bone-marrow biopsy in 9 patients (16%). The use of enzymatic assay became more frequent after 1990. The delay between first hospitalization due to GD symptoms and definitive diagnosis was less than one year for 38 patients. Patients with suspected GD were mainly referred to an internist physician. CONCLUSION GD seems to be better recognized and quickly diagnosed since 1990 in spite of the multiplicity of journeys. The role of the internist seems important.
Collapse
Affiliation(s)
- S Deriaz
- CHRU, université de Tours, service de médecine interne, Tours, France
| | - C Serratrice
- Service de médecine interne, hôpital Saint-Joseph, Marseille, France; Département de médecine interne et réhabilitation, hôpital universitaire de Genève, Suisse
| | - O Lidove
- Service de médecine interne, hôpital de la Croix Saint-Simon, Paris, France
| | - E Noël
- Service de médecine interne, CHRU de Strasbourg, Strasbourg, France
| | - A Masseau
- Service de médecine interne, CHRU de Nantes, Nantes, France
| | - B Lorcerie
- Service de médecine interne, CHRU de Dijon, Dijon, France
| | - R Jaussaud
- Service de médecine interne, CHRU de Reims, Reims, France
| | - I Marie
- Service de médecine interne, CHRU de Rouen, Rouen, France
| | - C Lavigne
- Service de médecine interne, CHRU d'Angers, Angers, France
| | - J Cabane
- Service de médecine interne, hôpital Saint-Antoine, Paris, France
| | - P Kaminsky
- Service de médecine interne, CHRU de Nancy, Nancy, France
| | - P Chérin
- Service de médecine interne, hôpital de la Pitié-Salpétrière, Paris, France
| | - F Maillot
- CHRU, université de Tours, service de médecine interne, Tours, France.
| | | |
Collapse
|
14
|
Montagner C, Bricou A, Selle F, Kafé H, Mauhin W, Fredeau L, Duval-Chopard L, Slama J, Durand P, Beal C, London J, Lidove O. [Glassy cell carcinoma of the uterine cervix: An aggressive type of cancer]. Rev Med Interne 2019; 40:754-757. [PMID: 31431320 DOI: 10.1016/j.revmed.2019.07.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2019] [Revised: 06/19/2019] [Accepted: 07/17/2019] [Indexed: 11/19/2022]
Abstract
INTRODUCTION Cervical cancer is the twelfth most frequent cancer in women in France. Glassy cell carcinoma is a rare histological entity, rapidly aggressive, associated with a poor prognosis. CASE REPORT A 30-year-old woman was admitted in an internal medicine department for polyarthralgia with high grade fever, evolving for 3 weeks. There was an inflammatory syndrome. The 18-FDG-PET-scan showed inflammatory lymph nodes as well as disseminated osteolytic lesions, and a primitive pelvic tumor. A 3cm tumor of the cervix was found during the gynaecologic examination. Histological analysis elicited a high-index mitotic carcinoma, glassy cell carcinoma type. Despite chemotherapy, the outcome was poor, with early death occurring after three months of follow-up. CONCLUSION The glassy cell carcinoma of the cervix should be considered as an aetiology of bone metastases in young female patients.
Collapse
Affiliation(s)
- C Montagner
- Service de médecine interne, Groupe Hospitalier Diaconesses Croix Saint Simon, rue d'Avron, 75020 Paris, France.
| | - A Bricou
- Service de chirurgie gynécologique et mammaire, Groupe Hospitalier Diaconesses Croix Saint Simon, rue d'Avron, 75020 Paris, France
| | - F Selle
- Service d'oncologie, Groupe Hospitalier Diaconesses Croix Saint Simon, rue d'Avron 75020 Paris, France
| | - H Kafé
- Centre de pathologie, 19, rue de Passy, 75016, France
| | - W Mauhin
- Service de médecine interne, Groupe Hospitalier Diaconesses Croix Saint Simon, rue d'Avron, 75020 Paris, France
| | - L Fredeau
- Service de médecine interne, Groupe Hospitalier Diaconesses Croix Saint Simon, rue d'Avron, 75020 Paris, France
| | - L Duval-Chopard
- Service de médecine interne, Groupe Hospitalier Diaconesses Croix Saint Simon, rue d'Avron, 75020 Paris, France
| | - J Slama
- Paris Service de médecine nucléaire, Hôpital Beaujon, 100, boulevard du Général Leclerc, 92110 Clichy, France
| | - P Durand
- Service de radiologie, Groupe Hospitalier Diaconesses Croix Saint Simon, rue d'Avron, 75020 Paris, France
| | - C Beal
- Service de rhumatologie, Groupe Hospitalier Diaconesses Croix Saint Simon, rue d'Avron, 75020 Paris, France
| | - J London
- Service de médecine interne, Groupe Hospitalier Diaconesses Croix Saint Simon, rue d'Avron, 75020 Paris, France
| | - O Lidove
- Service de médecine interne, Groupe Hospitalier Diaconesses Croix Saint Simon, rue d'Avron, 75020 Paris, France
| |
Collapse
|
15
|
Egal A, London J, Lidove O, Atienza P, Etienney I. [Anorectal manifestations in systemic diseases]. Rev Med Interne 2019; 40:729-732. [PMID: 31400822 DOI: 10.1016/j.revmed.2019.07.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2019] [Revised: 06/08/2019] [Accepted: 07/17/2019] [Indexed: 11/25/2022]
Abstract
Numerous systemic diseases (vasculitis, connective tissue disease or sarcoidosis) can display an involvement of the perianal skin, the rectum and/or the anus. Such knowledge is important in order to treat these complications specifically when possible. Lesions of the anorectum arising from systemic diseases can sometimes cause perforations in the peritoneal cavity (if concerning the higher portion of the rectum) and/or fistulization to the anal margin. Differential diagnosis, mostly infectious or inflammatory (Crohn's disease) must be ruled out in every case. Other systemic diseases can display specific manifestations as this is the case in scleroderma which can lead to anal incontinence. Despite the relative rarity of these manifestations, their ignorance would forbid global management of these complex diseases. It should thus be detected in each consultation and a regular follow-up must be provided with a proctologist and/or a gastroenterologist when needed.
Collapse
Affiliation(s)
- A Egal
- Service de proctologie chirurgicale, hôpital Croix Saint-Simon, 75020 Paris, France.
| | - J London
- Service de médecine interne, hôpital Croix Saint-Simon, 75020 Paris, France
| | - O Lidove
- Service de médecine interne, hôpital Croix Saint-Simon, 75020 Paris, France
| | - P Atienza
- Service de proctologie chirurgicale, hôpital Croix Saint-Simon, 75020 Paris, France
| | - I Etienney
- Service de proctologie chirurgicale, hôpital Croix Saint-Simon, 75020 Paris, France
| |
Collapse
|
16
|
Lidove O, Dussol B, Lacombe D, Bedreddine N, Fouilhoux A, Ronco P, Genevaz D, Bekri S, Hagege A, Dupuis F, Germain D, Noel E. Besoins et attentes des patients atteints de la maladie de Fabry vis-à-vis de leur traitement en France : développement d’un Questionnaire des Attentes des Patients (QAP Fabry). Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
17
|
Michaud M, Sené T, Lidove O, Chazerain P, Urbanski G, Chiche L, Bienvenu B, Alric L, Sailler L, Caudrelier L, Giraud J, Gaches F. Efficacité et Tolérance du Tocilizumab en utilisation hors AMM en médecine interne : étude rétrospective multicentrique. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.03.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
18
|
Mauhin W, Lidove O, Leguy-Seguin V, Dussol B, Hachulla E, Douillard C, Noel E, Masseau A, Lacombe D, Lavigne C, Ly K, Benveniste O. Critères de classification phénotypique de la maladie de Fabry à partir de la cohorte française FFABRY. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
19
|
Chazal T, Khanine V, Lidove O, Godot S, Ziza JM. Ostéomalacie secondaire à une tumeur mésenchymateuse phosphaturique de révélation tardive. Rev Med Interne 2017; 38:412-415. [PMID: 27659744 DOI: 10.1016/j.revmed.2016.08.020] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2016] [Revised: 08/17/2016] [Accepted: 08/18/2016] [Indexed: 01/29/2023]
Affiliation(s)
- T Chazal
- Service de médecine interne et rhumatologie, groupe hospitalier diaconesses Croix-Saint-Simon, 125, rue d'Avron, 75020 Paris, France.
| | - V Khanine
- Service de médecine interne et rhumatologie, groupe hospitalier diaconesses Croix-Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| | - O Lidove
- Service de médecine interne et rhumatologie, groupe hospitalier diaconesses Croix-Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| | - S Godot
- Service de médecine interne et rhumatologie, groupe hospitalier diaconesses Croix-Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| | - J-M Ziza
- Service de médecine interne et rhumatologie, groupe hospitalier diaconesses Croix-Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| |
Collapse
|
20
|
Mauhin W, Benveniste O, Douillard C, Masseau A, Leguy-Seguin V, Noel E, Ziza J, Lavigne C, Ly K, Dussol B, Hachulla E, Lidove O. État des lieux de la cohorte française F.FABRY – à propos de 103 patients atteints de maladie de Fabry. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
21
|
Tran Ba SN, Lidove O, Dorent R, Debauchez M, Nataf P, Delahousse M, Karras A, Azeroual L, De Lentdecker P, Chauveheid MP, Sené T, Ziza JM. [Combined heart and kidney transplantation in Fabry's disease: Long-term outcomes in two patients]. Rev Med Interne 2016; 38:137-142. [PMID: 27241078 DOI: 10.1016/j.revmed.2016.03.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2015] [Revised: 02/09/2016] [Accepted: 03/19/2016] [Indexed: 10/21/2022]
Abstract
INTRODUCTION Fabry disease is a lysosomal storage disorder linked to an alpha-galactosidase A deficiency that can lead to heart and kidney failure. There is little data about the prognosis of patients who undergo a combined heart and kidney transplantation. CASE REPORTS Two brothers who were diagnosed with Fabry disease after the age of 30 years underwent a combined heart and kidney transplantation at respectively 49 and 42 years of age because of a severe hypertrophic cardiomyopathy with end stage renal failure. They are alive respectively 4 and 9 years after the transplantation. No recurrence of the disease in the transplanted organs has been found. CONCLUSION Combined heart and kidney transplantation in Fabry disease is an efficient therapy for the cardiomyopathy and kidney failure. Its prognosis can be good when the patients are carefully selected. However, an early diagnosis is critical in order to avoid a procedure associated with a high perioperative mortality.
Collapse
Affiliation(s)
- S-N Tran Ba
- Service de médecine interne-rhumatologie, hôpital de la Croix-Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| | - O Lidove
- Service de médecine interne-rhumatologie, hôpital de la Croix-Saint-Simon, 125, rue d'Avron, 75020 Paris, France; Centre de référence des maladies lysosomales, site Avron, 125, rue d'Avron, 75020 Paris, France.
| | - R Dorent
- Chirurgie cardiaque, hôpital Bichat-Claude-Bernard, Paris, France
| | - M Debauchez
- Chirurgie cardiaque, institut mutualiste Montsouris, Paris, France
| | - P Nataf
- Chirurgie cardiaque, hôpital Bichat-Claude-Bernard, Paris, France
| | | | - A Karras
- Néphrologie, HEGP, 20, rue Leblanc, 75015 Paris, France
| | - L Azeroual
- Néphrologie, hôpital Bichat-Claude-Bernard, Paris, France
| | | | - M P Chauveheid
- Médecine interne, hôpital Bichat-Claude-Bernard, Paris, France
| | - T Sené
- Service de médecine interne-rhumatologie, hôpital de la Croix-Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| | - J-M Ziza
- Service de médecine interne-rhumatologie, hôpital de la Croix-Saint-Simon, 125, rue d'Avron, 75020 Paris, France
| |
Collapse
|
22
|
Puyraimond-Zemmour D, Zeller V, Meyssonnier V, Godot S, Sené T, Lidove O, Ziza J. Insuffisance rénale aiguë secondaire à une cristallisation d’amoxicilline : une complication émergente ? Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.10.210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
23
|
Lidove O, Le Fèvre L, Goasguen N, Jamali M, Vercellino L, Garnier M, Khellaf M, Belmatoug N, Ziza JM. Déficit en sphingomyélinase acide et rupture splénique : splénectomie ou traitement conservateur ? Rev Med Interne 2015; 36:619-22. [DOI: 10.1016/j.revmed.2014.10.367] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2014] [Revised: 10/21/2014] [Accepted: 10/29/2014] [Indexed: 10/24/2022]
|
24
|
Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi B, Rigon MR, Cacoub P, Saadoun D. Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients. J Autoimmun 2015; 62:67-74. [PMID: 26162757 DOI: 10.1016/j.jaut.2015.06.005] [Citation(s) in RCA: 143] [Impact Index Per Article: 15.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2015] [Revised: 06/06/2015] [Accepted: 06/07/2015] [Indexed: 10/23/2022]
Abstract
OBJECTIVE To report the efficacy and safety of anti-TNF agents in patients with severe and/or refractory manifestations of Behçet's disease (BD). METHODS We performed a multicenter study of main characteristics and outcomes of anti-TNF alpha treatments [mainly infliximab (62%), and adalimumab (30%)] in 124 BD patients [48% of men; median age of 33.5 (28-40) years]. RESULTS Overall response (i.e. complete and partial) rate was 90.4%. Clinical responses were observed in 96.3%, 88%, 70%, 77.8%, 92.3% and 66.7% of patients with severe and/or refractory ocular, mucocutaneous, joint, gastro-intestinal manifestations, central nervous system manifestations and cardiovascular manifestations, respectively. No significant difference was found with respect to the efficacy of anti-TNF used as monotherapy or in association with an immunosuppressive agent. The incidence of BD flares/patient/year was significantly lower during anti-TNF treatment (0.2 ± 0.5 vs 1.7 ± 2.4 before the use of anti-TNF, p < 0.0001). The prednisone dose was significantly reduced at 6 and 12 months (p < 0.0001). In multivariate analysis, retinal vasculitis was negatively associated with complete response to anti-TNF (OR = 0.33 [0.12-0.89]; p = 0.03). The efficacy and relapse free survival were similar regardless of the type of anti-TNF agent used. After a median follow-up of 21 [7-36] months, side effects were reported in 28% of patients, including infections (16.3%) and hypersensitivity reactions (4.1%). Serious adverse events were reported in 13% of cases. CONCLUSION Anti-TNF alpha therapy is efficient in all severe and refractory BD manifestations. Efficacy appears to be similar regardless of the anti-TNF agent used (infliximab or adalimumab).
Collapse
Affiliation(s)
- H Vallet
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière hospital, 83, boulevard de l'Hôpital, Paris 75013, France; Centre national de référence maladies systémiques et autoimmunes rares, DHU Inflammation, Immunopathologie, Biothérapie, Université Paris VI-Pierre et Marie Curie, Paris, France
| | - S Riviere
- Department of Internal Medicine, Saint Eloi Hospital, Montpellier, France
| | - A Sanna
- Department of Clinical Epidemiology and Biostatistics, Saint Louis Hospital, France
| | - A Deroux
- Department of Internal Medicine, University Hospital, Grenoble, France
| | - G Moulis
- Department of Internal Medicine, University Hospital, Toulouse, France
| | - O Addimanda
- Department of Rheumatology, Santa Maria Nuova Hospital, Reggio Emilia, Italy
| | - C Salvarani
- Department of Rheumatology, Santa Maria Nuova Hospital, Reggio Emilia, Italy
| | - M Lambert
- Department of Internal Medicine, University Hospital, Lille, France
| | - P Bielefeld
- Department of Internal Medicine, University Hospital, Dijon, France
| | - P Seve
- Department of Internal Medicine, Croix Rousse Hospital, Lyon, France
| | - J Sibilia
- Department of Rheumatology, University Hospital, Strasbourg, France
| | - Jl Pasquali
- Department of Internal Medicine, University Hospital, Strasbourg, France
| | - Jb Fraison
- Department of Internal Medicine, Jean Verdier Hospital, Bondy, France
| | - I Marie
- Department of Internal Medicine, University Hospital, Rouen, France
| | - L Perard
- Department of Internal Medicine, Edouard Herriot Hospital, Lyon, France
| | - L Bouillet
- Department of Internal Medicine, University Hospital, Grenoble, France
| | - F Cohen
- Department of Internal Medicine, E3M Institut, Pitié Salpêtrière Hospital, Paris, France
| | - D Sene
- Department of Internal Medicine, Lariboisière Hospital, Paris, France
| | - Y Schoindre
- Department of Internal Medicine, Pitié Salpêtrière Hospital, Paris, France
| | - O Lidove
- Department of Internal Medicine, Croix Saint Simon Hospital, Paris, France
| | - P Le Hoang
- Department of Ophtalmology, Pitié Salpêtrière Hospital, Paris, France
| | - E Hachulla
- Department of Internal Medicine, University Hospital, Lille, France
| | - O Fain
- Department of Internal Medicine, Saint Antoine Hospital, Paris, France
| | - X Mariette
- Department of Rheumatology, Kremlin Bicetre University Hospital, Kremlin Bicetre, France
| | - T Papo
- Department of Internal Medicine, Bichat Hospital, Paris, France
| | - B Wechsler
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière hospital, 83, boulevard de l'Hôpital, Paris 75013, France; Centre national de référence maladies systémiques et autoimmunes rares, DHU Inflammation, Immunopathologie, Biothérapie, Université Paris VI-Pierre et Marie Curie, Paris, France
| | - B Bodaghi
- Department of Ophtalmology, Pitié Salpêtrière Hospital, Paris, France
| | - M Resche Rigon
- Department of Clinical Epidemiology and Biostatistics, Saint Louis Hospital, France
| | - P Cacoub
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière hospital, 83, boulevard de l'Hôpital, Paris 75013, France; Centre national de référence maladies systémiques et autoimmunes rares, DHU Inflammation, Immunopathologie, Biothérapie, Université Paris VI-Pierre et Marie Curie, Paris, France
| | - D Saadoun
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière hospital, 83, boulevard de l'Hôpital, Paris 75013, France; Centre national de référence maladies systémiques et autoimmunes rares, DHU Inflammation, Immunopathologie, Biothérapie, Université Paris VI-Pierre et Marie Curie, Paris, France.
| | | |
Collapse
|
25
|
Tran Ba S, Lidove O, Debauchez M, Nataf P, Delahousse M, Karras A, Azeroual L, Dorent R, De Lentdecker P, Chauveheid MP, Sené T, Ziza JM. Double transplantation cœur-rein au cours de la maladie de Fabry : suivi à long terme de deux patients. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
26
|
Stirnemann J, Rose C, Serratrice C, Dalbies F, Lidove O, Masseau A, Pers Y, Baron C, Belmatoug N. Impact de la pénurie d’imiglucérase sur la prise en charge et l’évolution des patients français atteints de maladie de Gaucher de type 1. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
27
|
Sené T, Lidove O, Sebbah J, Darondel J, Aaron L, Fain O, Zenone T, Joly D, Charron P, Ziza J. Événements rythmiques graves au cours de la maladie de Fabry : description de 9 cas issus d’une cohorte monocentrique de 49 patients. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
28
|
Lidove O, Belmatoug N, Froissart R, Lavigne C, Durieu I, Mazodier K, Serratrice C, Douillard C, Goizet C, Cathébras P, Besson G, Ziza J. Maladie de Niemann-Pick B : à propos de 28 cas chez l’adulte. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.249] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
29
|
Serratrice C, Belmatoug N, Masseau A, Rose C, Kaminsky P, Lidove O, Camou F, Maillot F, Leguy V, Magy-Bertrand N, Marie I, Verrot D. Prévalence des auto-anticorps au cours de la maladie de Gaucher. Une étude multicentrique. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.03.254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
30
|
Barbey F, Joly D, Noel E, Drouineau O, Krayenbühl PA, Lidove O. Fabry disease in a geriatric population. Clin Genet 2015; 88:499-501. [DOI: 10.1111/cge.12585] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2015] [Revised: 03/04/2015] [Accepted: 03/10/2015] [Indexed: 11/27/2022]
Affiliation(s)
- F. Barbey
- Centre of Molecular Diseases; Centre Hospitalier Universitaire Vaudois; Lausanne Switzerland
| | - D. Joly
- Department of Nephrology; Necker Hospital; Paris France
| | - E. Noel
- Department of Internal Medicine; Centre Hospitalier Universitaire; Strasbourg France
| | - O. Drouineau
- Department of Internal Medicine; Hospital Dieppe; Dieppe France
| | | | - O. Lidove
- Department of Internal Medicine and Rheumatology; Croix Saint Simon Hospital; Paris France
- xINSERM-UMRS 974; University Pierre et Marie Curie; Paris France
| |
Collapse
|
31
|
Tella E, Opletalova K, Deschamps L, Lidove O, Descamps V. Scorbut révélé par une vascularite leucocytoclasique. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
32
|
Lidove O, Noel E, Hachulla E, Gaches F, Douillard C, Darne B, Ly K, Lavigne C, Masseau A, Leguy V, Ziza J. Caractéristiques des douleurs au cours de la maladie de Fabry. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
33
|
Le Lay K, Manet M, Franck N, Chazerain P, Lidove O, Ziza J. Un cas de lymphome T « pilotrope » sous abatacept régressant à l’arrêt de la biothérapie. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
34
|
Le Fevre L, Lidove O, Goasguen N, Jamali M, Vercellino L, Garnier M, Khellaf M, Belmatoug N, Ziza J. Déficit en sphingomyélinase acide (Niemann-Pick B) et rupture splénique : splénectomie ou traitement conservateur ? Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.343] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
35
|
Kaminsky P, Barbey F, Jaussaud R, Dussol B, Gaches F, Leguy-Seguin V, Hachulla E, Zenone T, Lavigne C, Douillard C, Lidove O. Cohérence intrafamiliale des symptômes cliniques dans la maladie de Fabry. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
36
|
Deshayes S, Auboire L, Imbert B, Lidove O, Parienti JJ, Jaussaud R, Bienvenu B. Fréquence du phénomène de Raynaud et des anomalies capillaroscopiques dans la maladie de Fabry. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
37
|
Hermet A, Lidove O, Grimbert S, Zeller V, Ducroquet F, Ziza JM. Nécrose aiguë de l’œsophage. Rev Med Interne 2014; 35:393-5. [DOI: 10.1016/j.revmed.2013.06.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2012] [Accepted: 06/15/2013] [Indexed: 11/26/2022]
|
38
|
Lidove O, Zeller V, Chicheportiche V, Meyssonnier V, Ahmed Yahia S, Manet Chopin P, Ziza J. Manifestations ostéoarticulaires de la maladie de Fabry : à propos d’une cohorte de 40 patients. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
39
|
Kaminsky P, Lidove O, Jaussaud R, Gaches F, Leguy-Seguin V, Hachulla E, Lavigne C, Zenone T, Douillard C, Barbey F. Leçons à retenir de l’étude séméiologique des patients dépistés lors d’une enquête familiale dans la Maladie de Fabry. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
40
|
Kaminsky P, Barbey F, Jaussaud R, Gaches F, Leguy-Seguin V, Hachulla E, Zenone T, Lavigne C, Douillard C, Lidove O. Diagnostic de la maladie de Fabry : leçons d’une analyse sémiologique. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.10.085] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
41
|
Lugosi M, Sacré K, Lidove O, Chauveheid MP, Brihaye B, Laissy JP, Chauchard M, Papo T. Fibrose(s) rétropéritonéale(s) : stratégie diagnostique, pathologies associées et suivi à long terme d’une cohorte française. Rev Med Interne 2013; 34:591-9. [DOI: 10.1016/j.revmed.2013.02.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2012] [Revised: 12/06/2012] [Accepted: 02/04/2013] [Indexed: 11/15/2022]
|
42
|
Sacre K, Dehoux M, Chauveheid MP, Chauchard M, Lidove O, Roussel R, Papo T. Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: an observational study. J Clin Endocrinol Metab 2013; 98:3199-205. [PMID: 23760625 DOI: 10.1210/jc.2013-1394] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
CONTEXT Glucocorticoid therapy is being used in a wide variety of systemic disorders. Reference papers, published more than 20 years ago, showed no correlation between adrenal insufficiency risk and dose or duration of glucocorticoid therapy. OBJECTIVE Our objective was to evaluate the extent to which long-term glucocorticoid therapy damages the pituitary-adrenal axis in patients with systemic inflammatory disorders. DESIGN We conducted a retrospective observational study from January 2011 to August 2012. SETTING This was a monocentric study at the Department of Internal Medicine, Bichat Hospital, Paris-Diderot University, Paris, France. PARTICIPANTS Sixty consecutive patients who were receiving long-term prednisone therapy for systemic inflammatory disorders and in whom discontinuation of glucocorticoid treatment was planned. INTERVENTION A short Synacthen test was performed. A bolus of 0.25 mg 1-24-ACTH was injected in the morning, 24 hours after the most recent dose of prednisone. Cortisol was measured at baseline and 60 minutes after Synacthen injection. MAIN OUTCOME MEASURES We assessed frequency and risk estimate of pituitary-adrenal dysfunction. RESULTS Twenty-nine patients (48.3%) had adrenal insufficiency defined by a plasmatic cortisol <100 nmol/L (n = 13) at baseline (time 0) or <550 nmol/L (n = 16) 60 minutes after Synacthen injection. Cumulative dose (area under the receiver operating characteristic curve = 0.77 [95% confidence interval = 0.62-0.91], P = .007) and exposure (area under the receiver operating characteristic curve 0.80 [95% confidence interval = 0.67-0.93], P = .002) to prednisone were predictive for adrenal insufficiency based on a T0 <100 nmol/L. Prednisone was stopped in 29 of 31 patients (93.5%) showing a normal response to short Synacthen test; none of these patients required hydrocortisone replacement with a mean follow-up of 10 (± 6) months. CONCLUSION Adrenal insufficiency is frequent in patients treated with long-term glucocorticoids for systemic inflammatory disorders and is related to duration and cumulative dose of steroids.
Collapse
Affiliation(s)
- K Sacre
- Department of Internal Medicine, Paris Diderot University, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, F-75018, Paris, France
| | | | | | | | | | | | | |
Collapse
|
43
|
Sacre K, Dehoux M, Chauchard M, Gobert D, Pasqueloni E, Compain C, Alexandra JF, Chauveheid MP, Lidove O, Roussel R, Papo T. FRI0546 Pituitary-adrenal function after prolonged glucocorticoid therapy in systemic disorders. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.1673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
44
|
Pagnoux C, Quéméneur T, Ninet J, Perrodeau E, Diot E, Kyndt X, De Wazières B, Reny J, Puéchal X, Leberruyer P, Lidove O, Vanhille P, Godmer P, Albath-Sadiki A, Bienvenu B, Cohen P, Mouthon L, Ravaud P, Guillevin L. Treatment of systemic necrotizing vasculitides in patients≥65 years old: Results of the multicenter randomized CORTAGE trial. Presse Med 2013. [DOI: 10.1016/j.lpm.2013.02.069] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
45
|
Kaminsky P, Noel E, Jaussaud R, Leguy-Seguin V, Hachulla E, Zenone T, Lavigne C, Marie I, Maillot F, Masseau A, Serratrice C, Lidove O. Multidimensional analysis of clinical symptoms in patients with Fabry's disease. Int J Clin Pract 2013; 67:120-7. [PMID: 23305474 DOI: 10.1111/ijcp.12016] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
AIM Fabry's disease is an X-linked inherited lysosomal storage disorder caused by the deficient activity of alpha-galactosidase A. The interrelationships between clinical symptoms in Fabry patients have not yet been fully established. Using cluster and multivariate analysis, the aim of the study was to determine the relationships among clinical symptoms and organ involvement, and predictive clinical symptoms for disease severity. METHODS Clinical data obtained from 108 French Fabry patients were retrospectively collected and analysed using multiple correspondence analysis and hierachical ascendant classification. Multivariate analysis was also performed to determine among clinical symptoms predictors for cardiac disease (HRT), renal involvement (KDN) and brain complication (STR). RESULTS The cohort comprised 41 male patients (aged 28.9 ± 11.6 years) and 67 female patients (aged 40.4 ± 15.5 years). Three main clusters of clinical symptoms could be delineated, characterising disease progression: the first cluster grouped digestive disorders (found in 30% of the patients) and exercise intolerance (32%), the second, cluster dyshidrosis (47%), acroparesthesia (67%), angiokeratoma (44%) and cornea verticillata (54%), the third, cluster grouped KDN (30%), HRT (39%) and STR (25%) and hearing loss (44%). In univariate analysis, the patient age predicted HRT and KDN, dyshidrosis predicted HRT and STR, angiokeratoma predicted KDN and cornea verticilla and hearing loss predicted KDN, HRT and STR. In multivariate analysis, hearing loss and age were independent predictors of organ complication. CONCLUSION Among the various interrelated clinical symptoms occurring in Fabry disease, patients with dyshidrosis and particularly hearing disorders appear to be at higher risk of organ complications.
Collapse
Affiliation(s)
- P Kaminsky
- Department of Internal Medicine and Orphan Diseases, Reference Center in Inherited Metabolism Diseases, Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Cherin P, Kaminsky P, Serratrice C, Lidove O, Noel E, Masseau A, Lorcerie B, Maillot F, Jaussaud R, Lavigne C, Cabane J, Leporrier M. Parcours diagnostique de la maladie de Gaucher de type 1. Résultats d’une enquête multicentrique française portant sur 55 patients. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
47
|
Legrand F, Renneville A, Ackermann F, Fain O, Michel M, Hamidou M, Hatron PY, Lidove O, Bletry O, Rousselot P, Prin L, Kahn J.E. Arrêt de l’imatinib dans la leucémie chronique à éosinophiles FIP1L1-PDGFRA en rémission moléculaire : résultats d’une étude rétrospective chez 11 patients. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
48
|
Cherin P, Serratrice C, Kaminsky P, Lidove O, Noel E, Masseau A, Lorcerie B, Maillot F, Jaussaud R, Lavigne C, Marie I, Cabane J. Troubles de la coagulation et de la fibrinolyse dans la maladie de Gaucher de type 1 : résultats d’une enquête multicentrique française portant sur 42 patients. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
49
|
Pagnoux C, Quéméneur T, Ninet J, Perrodeau E, Diot E, Kyndt X, de Wazieres B, Rény JL, Puéchal X, Leberruyer PY, Lidove O, Guillevin L. Traitement des vascularites systémiques nécrosantes chez les sujets plus ou moins 65ans : résultats de l’essai multicentrique randomisé CORTAGE. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.10.101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
50
|
Pichon M, Lidove O, Roudaire ML, Barry B, Herman P, Gobert D, Pasqualoni E, Compain C, Chauveheid MP, Papo T. [Auditory and vestibular findings in Fabry disease: a study of 25 patients]. Rev Med Interne 2012; 33:364-9. [PMID: 22365473 DOI: 10.1016/j.revmed.2012.01.014] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2011] [Revised: 01/05/2012] [Accepted: 01/21/2012] [Indexed: 11/28/2022]
Abstract
PURPOSE Fabry disease (FD, OMIM 301500) is an X-linked lysosomal storage disorder due to deficient activity of the enzyme alpha-galactosidase A. Males and females exhibit severe organ involvement. The high incidence of otological symptoms was recently reported. PATIENTS AND METHODS Monocentric and retrospective study of twenty-five patients with FD (13 families; seven males and 18 females). The patients underwent audiological assessment before initiation and during enzyme replacement therapy. We also analysed neurologic heart and kidney status. RESULTS Twenty patients (80%; 13 females and seven males) complained of otologic symptoms. Audiological evaluation showed a sensorineural hearing loss in 17 patients, bilateral in 16 out of them. Vestibular examination showed a functional impairment in two patients (one female, one male). Correlations were found between hearing loss and either kidney disease (73,3%), neurological complications (100%) and cardiomyopathy (80%). Fourteen patients (56%; seven females, seven males) received enzyme replacement therapy. Improvement or stabilization of the audiological evaluation was reported in seven patients, whereas worsening was observed in three patients. CONCLUSION This study confirms the high frequency of audiological involvements in females and males with FD. Our analysis suggests that the frequency of hearing loss is increased in the presence of renal or neurologic involvement or cardiomyopathy. There is no clinically significant efficacy of enzyme replacement therapy on hearing function. Although the pathophysiology remains unknown, a vascular mechanism responsible of the inner ear involvement seems to be privileged.
Collapse
Affiliation(s)
- M Pichon
- Service de médecine interne, hôpital Bichat Claude Bernard, 46, rue Henri-Huchard, 75877 Paris cedex 18, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|